Evoke Pharma Inc. (EVOK)

[cash_cow1]

Gimoti has its FDA approval for Gimoti Nasal Spray. The Bad Market today can't take that away. The stock may not have received its fair share price today for an important drug in demand treatment needed around the world, Gimoti Nasal Spray will get its fair share price. One way or the other. We own a very valuable treatment drug for Diabetic Gastroparesis disease that is in great demand. Gimoti the first of its kind to treat Diabetic Gastroparesis disease in 85% of adult females suffers with symptoms cause by the disease such as nausea, vomiting, Pain and Bloating.

Diabetic Gastroparesis is a disease which delay or slows the gastric emptying of the stomach contents after a meal and oral medication, which intern interferes with the glucose level in the blood. Gastroparesis disease is a $4 billion annual medical prescription to treat the disease and Gimoti Nasally form of metoclopramide is the first of its kind to treat diabetic gastroparesis in adult females.